HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,469,982 | +15.4% | 21,350 | 0.0% | 0.84% | +26.7% |
| Q2 2023 | $2,140,765 | -13.4% | 21,350 | -4.0% | 0.66% | -18.0% |
| Q1 2023 | $2,472,643 | -6.9% | 22,244 | -4.7% | 0.81% | -10.7% |
| Q4 2022 | $2,657,230 | +83.9% | 23,350 | 0.0% | 0.91% | +63.2% |
| Q3 2022 | $1,445,000 | -22.9% | 23,350 | -0.6% | 0.56% | -24.9% |
| Q2 2022 | $1,874,000 | -20.8% | 23,500 | +4.4% | 0.74% | -15.3% |
| Q1 2022 | $2,367,000 | -2.4% | 22,500 | 0.0% | 0.87% | -1.0% |
| Q4 2021 | $2,425,000 | -1.6% | 22,500 | 0.0% | 0.88% | -12.7% |
| Q3 2021 | $2,465,000 | +17.0% | 22,500 | 0.0% | 1.01% | +17.2% |
| Q2 2021 | $2,107,000 | +1.7% | 22,500 | 0.0% | 0.86% | -6.7% |
| Q1 2021 | $2,071,000 | +21.8% | 22,500 | -3.2% | 0.92% | +13.0% |
| Q4 2020 | $1,701,000 | +71.8% | 23,250 | +82.4% | 0.82% | +51.8% |
| Q3 2020 | $990,000 | +39.6% | 12,750 | 0.0% | 0.54% | +31.1% |
| Q2 2020 | $709,000 | +87.6% | 12,750 | 0.0% | 0.41% | +53.4% |
| Q1 2020 | $378,000 | – | 12,750 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |